paclitaxel has been researched along with Acute Coronary Syndrome in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (30.00) | 29.6817 |
| 2010's | 20 (66.67) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abellan-Huerta, J; Jurado-Roman, A; Lopez-Lluva, MT; Lozano-Ruiz-Poveda, F; Perez-Diaz, P; Pinilla-Echeverri, N; Piqueras-Flores, J; Sanchez-Perez, I | 1 |
| Baber, U; Camenzind, E; Chieffo, A; Dangas, GD; Faggioni, M; Farhan, S; Galatius, S; Giustino, G; Harari, R; Itchhaporia, D; Jeger, RV; Kandzari, D; Kastrati, A; Kim, HS; Kimura, T; Leon, MB; Mehran, R; Mehta, L; Morice, MC; Sartori, S; Serruys, PW; Sharma, M; Smits, PC; Sorrentino, S; Stefanini, GG; Steg, PG; Stone, GW; Valgimigli, M; Von Birgelen, C; Weisz, G; Wijns, W; Windecker, S | 1 |
| Gobeil, F; Mansour, S; Marquis-Gravel, G; Matteau, A; Noiseux, N; Potter, BJ; Stevens, LM | 1 |
| Eränen, J; Kärkkäinen, JM; Mäntylä, P; Mustonen, J; Rissanen, TT; Siljander, A; Uskela, S | 1 |
| Galbraith, PD; Ghali, WA; Knudtson, ML; Leung, AA; Philpott, AC; Southern, DA | 1 |
| Egami, Y; Hamasaki, T; Hara, M; Kato, H; Lee, Y; Makino, N; Nakamura, D; Nishino, M; Sakata, Y; Shutta, R; Taniike, M; Tanouchi, J; Yamada, Y; Yoshimura, T | 1 |
| Baumgartner, S; Garcia-Garcia, HM; Jüni, P; Justiz, J; Kalesan, B; Meier, B; Moschovitis, A; Pilgrim, T; Räber, L; Taniwaki, M; Wenaweser, P; Windecker, S; Zanchin, T | 1 |
| Daida, H; Kasai, T; Konishi, H; Miyauchi, K; Naito, R; Ogita, M; Okazaki, S; Tamura, H; Tsuboi, S | 1 |
| Capelan, M; Lote, H; Mohammed, K; Papadimitraki, E; Redana, S; Ring, A; Sharp, A | 1 |
| Gobić, D; Lulić, D; Tomulić, V; Zaputović, L; Židan, D | 1 |
| Batsolaki, M; Chiladakis, JA; Gouvelou-Deligianni, GV; Kounis, GN; Kounis, NG; Kounis, SA; Soufras, GD | 1 |
| Cinçin, A; Değertekin, M; Gemici, G; Oktay, A | 1 |
| Daemen, J; Garcia-Garcia, HM; Kukreja, N; Onuma, Y; Serruys, PW; van Domburg, R | 1 |
| Berger, P; Cohen, DJ; Cutlip, D; Goldberg, S; Hong, M; Kellett, M; Kleiman, N; Mauri, L; Novack, V; Pencina, M; Raizner, AE; Waksman, R; Yen, CH | 1 |
| Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; de Lemos, JA; Fasseas, P; Haagen, D; Holper, EM; Iturbe, JM; Kar, B; Karyofillis, P; Lichtenwalter, C; Obel, O; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Shunk, K; Voudris, VV | 1 |
| Endoh, A; Imai, K; Ishikawa, T; Kubota, T; Miyamoto, T; Mochizuki, S; Murakami, M; Mutoh, M; Nakano, Y; Nakata, K; Sakamoto, H; Suzuki, T; Yoshimura, M | 1 |
| Gothwal, R; Kumar, A | 1 |
| Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F | 1 |
| Juwana, YB; Ottervanger, JP; Rasoul, S; Suryapranata, H | 1 |
| Alexopoulos, D; Damelou, A; Davlouros, PA; Karantalis, V; Mavronasiou, E; Nikokiris, G; Tsigkas, G; Xanthopoulou, I | 1 |
| Cohen, DJ; Dhar, G; Keyes, MJ; Kleiman, NS; Lopez, JJ; Marquardt, W; Marso, S; Nathan, S; Pencina, M; Piana, R; Rao, S; Shammo, S | 1 |
| Applegate, RJ; Cohen, DJ; Gandhi, SK; Kutcher, MA; Little, WC; Sacrinty, MT; Santos, RM; Schafer, PE | 1 |
| Fahy, M; Kedhi, E; Kereiakes, DJ; Planer, D; Serruys, PW; Smits, PC; Stone, GW; Xu, K | 1 |
| Diamond, GA; Kaul, S | 1 |
| Böhm, M; Clever, Y; Cremers, B; Scheller, B | 1 |
| Braunersreuther, V; Mach, F; Montecucco, F | 1 |
| Akkerhuis, KM; Boersma, E; Daemen, J; de Boer, SP; de Jaegere, P; Marcolino, MS; Serruys, PW; Simsek, C; van Domburg, RT; van Geuns, RJ | 1 |
| Buszman, PE; Buszman, PP; Drzewiecki, J; Granada, JF; Kaluza, GL; Kozlowski, M; Milewski, K; Orlik, B; Peppas, A; Pruski, M; Trela, B | 1 |
| Cottin, Y | 1 |
| Carrié, D; Cherradi, R; Elbaz, M; Ouldzein, H; Puel, J; Zouaoui, W | 1 |
1 review(s) available for paclitaxel and Acute Coronary Syndrome
| Article | Year |
|---|---|
Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Coronary Restenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Treatment Outcome | 2010 |
6 trial(s) available for paclitaxel and Acute Coronary Syndrome
| Article | Year |
|---|---|
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Graft Occlusion, Vascular; Greece; Humans; Metals; Myocardial Infarction; Paclitaxel; Prosthesis Design; Recurrence; Saphenous Vein; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Biomarkers; Cardiac Catheterization; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Humans; Italy; Longitudinal Studies; Paclitaxel; Prosthesis Design; Research Design; Single-Blind Method; Thrombosis; Time Factors; Tomography, Optical Coherence; Trapidil; Treatment Outcome; Vascular Endothelial Growth Factor A | 2010 |
Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Diagnosis, Differential; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prognosis; Prospective Studies; Prosthesis Failure; Time Factors; Tomography, Optical Coherence; Tunica Intima | 2011 |
Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era.
Topics: Acute Coronary Syndrome; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; United States | 2010 |
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimu
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Netherlands; Odds Ratio; Paclitaxel; Sirolimus; Time Factors; Treatment Outcome; United States | 2011 |
Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
23 other study(ies) available for paclitaxel and Acute Coronary Syndrome
| Article | Year |
|---|---|
Long-Term Follow-Up of Percutaneous Coronary Intervention With Paclitaxel-Eluting Balloon Catheter.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Time Factors; Treatment Outcome | 2021 |
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; ST Elevation Myocardial Infarction; Treatment Outcome | 2017 |
Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Prosthesis Design; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2017 |
Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2019 |
Time dependency of outcomes for drug-eluting vs bare-metal stents.
Topics: Acute Coronary Syndrome; Aged; Alberta; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Patient Outcome Assessment; Propensity Score; Proportional Hazards Models; Prospective Studies; Registries; Risk; Sirolimus; Stents; Survival Rate; Time Factors | 2013 |
Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Cohort Studies; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Sirolimus; Tomography, Optical Coherence | 2014 |
Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Tomography, Optical Coherence; Treatment Outcome; Tubulin Modulators; Wound Healing | 2014 |
Comparison of long-term clinical outcomes between sirolimus- and paclitaxel-eluting stents in real-world clinical practice.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Thrombosis; Treatment Outcome | 2015 |
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.
Topics: Acute Coronary Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Incidence; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pulmonary Embolism; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Stroke; Taxoids; Thromboembolism; Venous Thrombosis | 2016 |
Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atherosclerosis; Cell Adhesion Molecules; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Metals; P-Selectin; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2016 |
Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel and the risk of Kounis syndrome.
Topics: Acute Coronary Syndrome; Drug Hypersensitivity; Drug-Eluting Stents; Humans; Paclitaxel | 2009 |
Paclitaxel-induced ST-segment elevations.
Topics: Acute Coronary Syndrome; Administration, Sublingual; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Biomarkers; Carcinoma; Coronary Angiography; Coronary Vasospasm; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Infusions, Intravenous; Middle Aged; Nitroglycerin; Ovarian Neoplasms; Paclitaxel; Stents; Treatment Outcome; Troponin T; Vasodilator Agents | 2009 |
The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies.
Topics: Acute Coronary Syndrome; Angina, Unstable; Clinical Trials as Topic; Drug-Eluting Stents; Europe; Humans; Incidence; Japan; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Sirolimus; Thrombosis; Ticlopidine; United States | 2009 |
Letter to the editor. Paclitaxel-Induced ST-segment elevations: A manifestation of allergic acute coronary syndrome (Kounis Syndrome) [corrected].
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug Hypersensitivity; Humans; Paclitaxel; Syndrome | 2009 |
Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.
Topics: Acute Coronary Syndrome; Aged; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Sirolimus | 2011 |
Should everolimus-eluting stents be preferred in patients with acute and stable coronary syndromes?
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Sirolimus | 2011 |
Drug coated balloons in acute coronary syndromes--opportunities and limitations.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Arrhythmias, Cardiac; Combined Modality Therapy; Coronary Restenosis; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Surface Properties; Thrombosis | 2012 |
Statins and stent thrombosis.
Topics: Acute Coronary Syndrome; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Paclitaxel; Prosthesis Design; Sirolimus; Stents | 2012 |
Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Equipment Failure; Female; Humans; Longitudinal Studies; Male; Middle Aged; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Risk Factors; Sirolimus; Stents; Treatment Outcome | 2012 |
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Angina, Stable; Cardiovascular Agents; Coronary Stenosis; Coronary Thrombosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Poland; Polymers; Propensity Score; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |
Stenting for unprotected left main coronary artery stenosis: a further step.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Time Factors; Treatment Outcome | 2008 |